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Abstract
Objective: To assess European pediatric rheumatology providers’ current clinical practices and resources used in
the transition from child-centered to adult-oriented care.
Methods: European pediatric rheumatologists were invited to complete a 17-item anonymized e-survey assessing
current transition practices, transition policy awareness, and needs in advance of the publication of EULAR/PReS
recommendations on transition.
Results: The response rate was 121/276 (44%), including responses from 115 centers in 22 European Union
countries. Although 32/121 (26%) responded that their centers did not offer transition services, the majority
(99%) agreed that a formalized process in transitioning patients to adult care is necessary. A minority (<30%) of
respondents stated that they have a written transition policy although 46% have an informal transition process.
Designated staff to support transitional care were available in a minority of centers: nurse (35%), physiotherapist
(15%), psychologist (15%), social worker (8%), and occupational therapist (2%). The existence of a designated team
member to coordinate transition was acknowledged in many centers (64% of respondents) although just 36% use a
checklist for young people as part of individualized transitional care.
Conclusion: This survey of European pediatric rheumatology providers regarding transitional care practices
demonstrates agreement that transitional care is important, and wide variation in current provision of transition
services exists.
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Juvenile onset rheumatic and musculoskeletal diseases
(jRMDs) have high impact on all aspects of the lives of
children, young people (YP) and their families. Based on
prevalence rates, it is estimated that there are 75,000
children under 16 years old with juvenile idiopathic
arthritis (JIA) [1] and about 2500 with systemic lupus
erythematosus (SLE) in Europe [2]. These conditions
persist into adulthood for many individuals, with continu-
ing disease activity and need for ongoing medication with
potential disease-associated morbidity, life-long disability
and psychosocial impact [3–5]. During the period of tran-
sition, YP with jRMDs have to cope with tremendous
physical, emotional and social changes and also with im-
portant change in the delivery of clinical care as they move
into adult services. Providing transitional care services
during this period is necessary to ensure that YP can take
control of their health care needs, engage with health care
providers and ultimately emerge into adulthood with their
optimal function and potential [6, 7]. High-quality, devel-
opmentally appropriate healthcare service provision re-
quires the involvement of the YP and the family and also a
continuous communication between all persons and pro-
vider services involved in transitional care [8].
Whilst the rationale and aims of transitional care in
young people with jRMD are clear, organization and deliv-
ery of transitional care and what constitutes the ideal ser-
vice, remains unclear [9, 10]. Previous surveys in the UK,
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North America and Europe [11–13] have demonstrated
variable provision of care and resources, unmet education
and training needs for health care providers, and the need
for guidance on the process. This state of play facilitated
the drive for the EULAR/PReS working party for transi-
tional care to be set up in 2014 with subsequent published
recommendations [14]. The purpose of our survey was to
assess as a baseline, the European pediatric rheumatology
providers’ transition practices and resources in advance of
the EULAR/PReS recommendations for transition being
widely available.
Methods
European pediatric rheumatologists were invited to
complete an anonymized 17-item e-survey assessing
their current transition practice. The questionnaire was
developed by the authors (DC, LL, HF, LC, KM) after a
systematic literature review and critical appraisal of
transitional care programs in rheumatology [10] and
two face-to-face meetings of the EULAR/PReS working
party for transitional care [14]. Items were included
that enquired about current transition practices, agreed
key elements of transition programs and available re-
sources (see Additional file 1). For comparability rea-
sons, items 1 to 3 were matched with questions of the
North-American CARRA survey by Chira et al. [12]. The
survey was distributed by the Coordinating Centre of
PRINTO (Pediatric Rheumatology INternational Trials
Organisation) via SurveyMonkey© to the PRINTO direc-
tors of all PRINTO centers in 25 European Union coun-
tries. PRINTO is an international network of academic,
clinical centers actively engaged in the research/clinical
care of children and adolescents with pediatric rheumatic
diseases. One reminder was sent to increase the response
rate. The questionnaire included items about the tran-
sitional care service, staffing, process and resources.
The e-survey was piloted by the authors to optimize clar-
ity and ease of administration online.
The study was conducted in cooperation with PRINTO.
We did not collect personal identifiable information, such
as telephone numbers, names of individuals or institutions,
or addresses. The survey respondents voluntarily partici-
pated in the study giving their consent to data collection
for the purpose of scientific research.
Descriptive statistics are presented and where possible
the results were compared with the North American
2014 survey [12] using proportions z test statistical ana-
lysis, assuming independence of the two cohorts and
α = 0.01, given the multiple comparisons being made
[15, 16]. The responses of rheumatology centers from
different levels of care were compared by the chi-squared
test. The 99% CI of the difference between surveys is
provided.
Results
Respondent demographics and characteristics
The link to the survey was e-mailed to pediatric rheu-
matologists (n = 276) from PRINTO centers in 25
European Union countries in April 2016. Of these, 121
responded (44% response rate), representing 115 cen-
ters in 22 countries, and thus much of the European
Union. Exceptions were Bulgaria, Estonia and Lithuania
from whom no responses were received, and Cyprus,
Malta and Luxemburg which do not currently have
PRINTO centers. The 115 centers who responded cor-
respond to 88% of the PRINTO centers currently listed
on the PRINTO-website in those 22 countries. These
represent centers with a special interest in research and
potentially more likely to have an interest in transition.
Most respondents (n = 60; 49%) work in a university-
affiliated practice, 39% (n = 47) in a designated chil-
dren’s hospital, 4% (n = 5) in private practice and 7%
(n = 8) in other settings.
Transition policy, staff involved, tools and
resources
Most (n = 120; 99%) respondents regarded a transition
policy as being necessary for good clinical practice. The
majority stated that they follow an informal transitional
care with only one in four centers having a written tran-
sition policy (Table 1). Most rheumatology centers (re-
spondents n = 88; 73%) regularly offer transition services
for YP with rheumatic diseases, with a wide range of
Table 1 Current transition policies at the respondents’ units
Regarding transition policies….* Number Percent
We have a written transition policy, which we follow most of the time. 29 23.9
We have a written transition policy, but we do not follow it most of the time. 4 3.3
We do not have a written transition policy, but follow a fairly standard, informal procedure in transitioning our patients. 56 46.2
We are working on developing a transition policy, but do not yet have one formalized. 21 17.3
We do not have a transition policy, but are interested in developing one. 10 8.2
I do not think that a transition policy is necessary at this point. 1 .8
I have not given it much thought. 0 -
*Percent obtained from 121 affirmative responses
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health professionals involved including pediatric and
adult rheumatologists and nurses being most common
(Table 2). There is a designated staff member who has
primary responsibility for coordinating transition process
in approximately two thirds of centers (respondents
n = 77, 64%); the staff member is often a doctor (n = 60;
78%) or a nurse specialist (n = 14; 18%). A minority (re-
spondents n = 9/119; 7.6%) of transition units receive
designated funding or reimbursement for their services,
with health insurance companies, grants, pharmaceutical
companies, or university as sources.
A minority of centers (respondents n = 44; 36.4%) use
a checklist as part of an individualized transition plan
that includes the topics shown in Table 3. The majority
of these (40/44; 90.9%), agreed that confirmation of the
first contact with adult rheumatologist is critical. Other
important topics were the importance of knowledge
about disease and treatment issues (39/44; 88.6%), as
were the encouraging self-management and independent
visits by YP without their parents (35/44; 79.5%).
Of note, less than 10% of centers (respondents n = 11)
use a specific readiness for transfer instrument, of these,
five use a self-developed readiness scale. Other instruments
used are the Transition Readiness Assessment Question-
naire (TRAQ), TRANSITION Scale, Ready Steady Go [17].
A minority of respondents (18/121; 15%) reported to
use or recommend specific resources for YP and their
families. These were mainly websites providing infor-
mation on juvenile rheumatic diseases, but also on
transition aspects, such as the PRINTO website
[www.printo.it/pediatric-rheumatology] and the web-
site on transition of the Competence Network Patient
Training in Adolescence KomPaS e. V. [www.between-
kompas.de]). Furthermore, a minority (38/121; 31%)
use information technology to facilitate communication
with YP; mainly Short Message Service (SMS), web
platforms, email, or apps and the remainder tend to
communicate by telephone.
Among the rheumatology centers from different models
of care, some differences regarding transition care were
observed. In comparison to children’s hospitals, University
affiliated practices provided somewhat less often transition
services (69% vs. 78%), had less often a written transition
policy (22% vs. 41%) and used significantly less frequently
a checklist as part of individualized transitional care (23%
vs. 48%, p = 0.011).
Figure 1 is a pragmatic attempt to compare the data
from our survey and previous published data from North
America [12]. Notably the majority of North American re-
spondents (89%) work in a University-affiliated practice in
contrast to 49% of their European colleagues (p < 0.01;
99% CI: 0.29, 0.49). Current transitional care services in
Europe and North America show significant differences;
the presence of a designated staff member who coordi-
nates transition (64% in Europe vs 30% in North America;
p < 0.01; 99% CI: -0.45, −0.22) and the availability of a
Table 2 Staff involved in the transition services of the
respondents’ units
Health professionals in the transition service Number Percent
Pediatric rheumatologist 92 76.0




Social worker 10 8.2
Occupational therapist 3 2.4
Othersa 11 9.0
aInclude: internist, medical assistant, expert patients, orthopedic
surgeon, gynecologist
Table 3 Components of existing individualized transition plans
Checklist componentsa Number Percent
Self-management, patient is seen without parents 35 79.5
Disease and treatment knowledge 39 88.6
Name of disease 39 88.6
Being able to describe disease course 32 72.7
Signs and symptoms of disease flare 33 75.0
Signs and symptoms that require an urgent
consultation
30 68.1
Treatment information 40 90.9
Possible side effects of treatment 36 81.8
Health behavior 31 70.4
Risk behavior 29 65.9
Alcohol use, smoking, illegal drugs use 35 79.5
Nutrition 27 61.3
Sports 31 70.4
Mental health 27 61.3
Sexuality, contraception and sexual health 34 77.2
Future plans 33 75.0
Educational achievements 30 68.1
Vocational readiness 22 50.0
Knowledge of support resources 28 63.6
Mobility, living alone, travel 24 54.5
Medical summary available 34 77.2
Knowledge of differences between pediatric and
adult rheumatology care
36 81.8
Knowledge about the health system (health
insurance, general practitioner/family doctor,
health care specialist)
21 47.7
Transfer readiness 28 63.6
First contact to adult rheumatologist 40 90.9
aPercent obtained from 44 affirmative responses on having a checklist
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written transition policy (26% in Europe vs 8% in North
America; p < 0.001; 99% CI: -0.26, −0.08). Nevertheless,
the percent of informal transition process is similar across
surveys (46% vs. 42%; non-significant).
Discussion
This is the first survey to focus on the current practices
(rather than solely attitudes or opinions) in transitional
care among European pediatric rheumatology providers.
As in other chronic diseases that start in childhood, YP
with jRMD need specific care during the period of transi-
tion from pediatric services to the adult specialty care set-
ting. However, research about current practice and the
implementation of transition recommendations are scarce
and almost half of the YP with jRMD do not make a suc-
cessful transfer to adult rheumatology and are, therefore,
at increased risk of unfavorable outcomes [5, 18, 19].
Recently, EULAR/PReS recommendations were issued
for transitional care throughout Europe [14]. These rec-
ommendations were published after the e-survey was
conducted and so our data serve as useful benchmark of
current practice. The recommendations highlight the
need for a written transition policy, and yet less than a
third of respondents in our survey indicated that their
department had a formal transition program; an ‘informal
approach’ was reported to be more common although fur-
ther information was not given in the survey. It is hoped
that the use of the recommendations and a consistent ap-
proach to the transition program is more likely to address
the structure, assessments of patient readiness and service
outcomes. We note that only a small percentage of transi-
tion clinics receive funding or reimbursement for the ser-
vice and it is possible that one barrier to implement more
ambitious transition programs may be insufficient re-
sources. Interestingly, the EULAR/PReS recommendations
include the need to secure funding for provision of transi-
tional care, in order to avoid some of the major barriers as
highlighted by the North American survey and a frequent
shortcoming in Europe [14].
The presence of a transition coordinator is another
key element of transition and one of the EULAR/PReS
recommendations; the aim being to ensure implementa-
tion and evaluation of the transition program and im-
proving communication between health professionals,
YP and families [8, 14]. Most respondents of the survey
have a designated staff member as transition coordinator.
However, in contrast to the recommendations, emphasiz-
ing the important role of allied health professionals in
transition coordination, we note that the designated staff
member is often a doctor rather than a nurse, youth
worker or other professional. The EULAR/PReS recom-
mendations do not specify whether the coordinator is a
doctor or allied health professional but that the individual
is clearly identified within the team and has the appropri-
ate skills to facilitate liaison between the pediatric and the
adult care teams [14].
Information and education of YP about their disease,
treatments and promotion of independent visits to clinic
without parents are ideal components of an individual-
ized transition plan. However, it is important to include
systematically other important areas of adolescence health,
such as risk behavior, substance use, sports, nutrition or
sexuality. The HEADSS assessment (Home, Education/
Employment, peer group, Activities, Drugs, Sexuality, Sui-
cide/depression) was developed [20] and has since been
successfully used to facilitate communication with YP and
Fig. 1 Comparison of transitional care services offered by European and Childhood Arthritis and Rheumatology Research Alliance (CARRA)
pediatric rheumatology providers
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as guide to cover all topics pertinent to young people in
the transition process. However, to address all relevant
transition issues, it might be necessary to have a multidis-
ciplinary team (i.e., psychologist to handle mental health
or physiotherapist to advice about sports and routine exer-
cises). This approach is clearly recommended in the
EULAR/PReS document [14]. Our survey revealed that
currently only a minority of centers offers multidisciplin-
ary transitional care services; 35% of the centers have a
nurse, 15% a psychologist and 8% a social worker available
for addressing transition-relevant issues.
Our survey did not specifically address timing of
transfer. However, it should be noted that only 9.5% use
a readiness instrument to validate transfer, reflecting the
informal approach to transition in the majority of cen-
ters. This issue was heavily discussed in the development
of the EULAR/PReS recommendations, as some coun-
tries had a designated age for transfer in all cases and in-
dependently of YP readiness. Ultimately the EULAR/
PReS recommendations propose that age per se is not
specifically used as the trigger for timing of the transfer.
Conversely, age is an important indicator for the initiation
of transitional care; namely that the transition process
should start as early as possible [14]. The recommenda-
tions also propose strategies to facilitate transfer including
communication with adult services before actual transfer
with relevant information about the YP or shared clinics
between pediatric and adult health care professionals. In
this way, the timing of transfer could be more flexible, and
could be deferred until the disease is stable and/or the
transition team consider the patient to be “ready”.
Where possible and with the questions that can be
compared, we were able to comment on differences
between European and North American respondents.
European providers more often do have a transition
coordinator (often a doctor) and are more likely to use
a written transition policy statement. In both surveys,
respondents manifest a strong desire for rheumatology-
specific guidelines for transition [12] and for these to be
implemented across pediatric, adolescent and adult
rheumatology health care settings.
In summary, this survey has demonstrated limitations
of existing transition practices and paucity of resources.
Nonetheless there is a strong commitment within the
rheumatology communities (both adult and pediatric), to
improve existing transitional care provision. The EULAR/
PReS recommendations are therefore timely and important
as a much needed catalyst for change within the rheumatol-
ogy community.
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